Optimizing Clinical Use of Polymyxin B
Optimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat Superbugs
Sponsor: Rutgers, The State University of New Jersey
A observational or N/A phase clinical study on Blood Stream Infection and Pneumonia, this trial is completed. The trial is conducted by Rutgers, The State University of New Jersey and has accumulated 19 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
19 versions recorded-
Dec 2024 — Present [monthly]
Completed
-
Sep 2024 — Dec 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2022 — Dec 2023 [monthly]
Recruiting
▶ Show 14 earlier versions
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Recruiting
-
Jul 2019 — Jun 2020 [monthly]
Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Apr 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rutgers, The State University of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .